These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 7807971)

  • 1. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.
    Okon E; Pouliquen D; Okon P; Kovaleva ZV; Stepanova TP; Lavit SG; Kudryavtsev BN; Jallet P
    Lab Invest; 1994 Dec; 71(6):895-903. PubMed ID: 7807971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.
    Briley-Saebo K; Bjørnerud A; Grant D; Ahlstrom H; Berg T; Kindberg GM
    Cell Tissue Res; 2004 Jun; 316(3):315-23. PubMed ID: 15103550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicity of magnetite-dextran particles: morphological study].
    Okon EE; Pulikan D; Pereverzev AE; Kudriavtsev BN; Zhale P
    Tsitologiia; 2000; 42(4):358-66. PubMed ID: 10849930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism.
    Pouliquen D; Le Jeune JJ; Perdrisot R; Ermias A; Jallet P
    Magn Reson Imaging; 1991; 9(3):275-83. PubMed ID: 1881245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodistribution of ultrasmall iron oxide particles in the rat liver.
    Van Beers BE; Sempoux C; Materne R; Delos M; Smith AM
    J Magn Reson Imaging; 2001 Apr; 13(4):594-9. PubMed ID: 11276104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
    Majumdar S; Zoghbi SS; Gore JC
    Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.
    Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A
    J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran magnetite as a liver contrast agent.
    Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
    Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-directed superparamagnetic iron oxide: quantitation of T2 relaxation effects.
    Pouliquen D; Lucet I; Chouly C; Perdrisot R; Le Jeune JJ; Jallet P
    Magn Reson Imaging; 1993; 11(2):219-28. PubMed ID: 8455432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. USPIO (Ferumoxtran-10)-enhanced MRI to visualize reticuloendothelial system cells in neonatal rats: feasibility and biodistribution study.
    Azoulay R; Olivier P; Baud O; Verney C; Santus R; Robert P; Gressens P; Sebag G
    J Magn Reson Imaging; 2008 Oct; 28(4):1046-52. PubMed ID: 18821607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolism.
    Briley-Saebo KC; Johansson LO; Hustvedt SO; Haldorsen AG; Bjørnerud A; Fayad ZA; Ahlstrom HK
    Invest Radiol; 2006 Jul; 41(7):560-71. PubMed ID: 16772849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long circulating superparamagnetic particles with high T2 relaxivity.
    Pochon S; Hyacinthe R; Terrettaz J; Robert F; Schneider M; Tournier H
    Acta Radiol Suppl; 1997; 412():69-72. PubMed ID: 9240083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10.
    Raynal I; Prigent P; Peyramaure S; Najid A; Rebuzzi C; Corot C
    Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T; Wolf G
    Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO) contrast medium uptake in experimental brain ischemia.
    Schroeter M; Saleh A; Wiedermann D; Hoehn M; Jander S
    Magn Reson Med; 2004 Aug; 52(2):403-6. PubMed ID: 15282824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI detection of macrophages labeled using micrometer-sized iron oxide particles.
    Williams JB; Ye Q; Hitchens TK; Kaufman CL; Ho C
    J Magn Reson Imaging; 2007 Jun; 25(6):1210-8. PubMed ID: 17520727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic iron oxide: pharmacokinetics and toxicity.
    Weissleder R; Stark DD; Engelstad BL; Bacon BR; Compton CC; White DL; Jacobs P; Lewis J
    AJR Am J Roentgenol; 1989 Jan; 152(1):167-73. PubMed ID: 2783272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation effects of clustered particles.
    Tanimoto A; Oshio K; Suematsu M; Pouliquen D; Stark DD
    J Magn Reson Imaging; 2001 Jul; 14(1):72-7. PubMed ID: 11436217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
    Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
    J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
    Moore A; Marecos E; Bogdanov A; Weissleder R
    Radiology; 2000 Feb; 214(2):568-74. PubMed ID: 10671613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.